These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 895010)

  • 1. Interaction of allopurinol with phenprocoumon in man.
    Jähnchen E; Meinertz I; Gilfrich HJ
    Klin Wochenschr; 1977 Aug; 55(15):759-61. PubMed ID: 895010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
    Harenberg J; Haas R; Zimmermann R
    Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concomitant use of suloctidil and a long-acting oral anticoagulant.
    Verhaeghe R; Vanhoof A
    Acta Clin Belg; 1977; 32(1):36-8. PubMed ID: 331824
    [No Abstract]   [Full Text] [Related]  

  • 4. Double blind study of the effect of glafenine (Glifanan) on oral anticoagulant therapy with phenprocoumon (Marcumar).
    Boeijinga JK; van der Vijgh WJ
    Eur J Clin Pharmacol; 1977 Dec; 12(4):291-6. PubMed ID: 22438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of naproxen on the thrombocyte bleeding time and on the anticoagulant treatment with phenprocoumon].
    Angelkort B
    Fortschr Med; 1978 Jun; 96(23):1249-52. PubMed ID: 658877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the interactions of chlordiazepoxide, nitrazepam, and diazepam with phenprocoumon (author's transl)].
    Kinawi A; Baumgartl I
    Arzneimittelforschung; 1976; 26(11):2019-23. PubMed ID: 1037237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
    Breddin HK; Uberla KK
    Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of daily administration of naproxen on the prothrombin complex activity in patients under long-term therapy with phenprocoumon.
    Petersen PB; Husted S; Mortensen A; Andreasen F
    Scand J Rheumatol; 1979; 8(1):54-6. PubMed ID: 311940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased effect of phenprocoumon (Marcumar) in nephrotic syndrome].
    Heni N; Völger R; Glogner P
    MMW Munch Med Wochenschr; 1980 Feb; 122(5):175-6. PubMed ID: 6767946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Migraine and marcumar].
    Behnen HJ
    Dtsch Med Wochenschr; 1979 Jan; 104(1):32-3. PubMed ID: 759135
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Haemostasis; 1980; 9(6):325-44. PubMed ID: 7005035
    [No Abstract]   [Full Text] [Related]  

  • 12. On the interaction between the anti-inflammatory substance proquazone (RU 43-715) and phenprocoumone.
    Vinazzer H
    Int J Clin Pharmacol Biopharm; 1977 May; 15(5):214-6. PubMed ID: 326688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma hypercoagulability after termination of oral anticoagulants.
    Harenberg J; Haas R; Zimmermann R
    Thromb Res; 1983 Mar; 29(6):627-33. PubMed ID: 6857601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient acquired resistance to the coumarin anticoagulants phenprocoumon and acenocoumarol.
    de Wolff FA; ten Cate JW
    Scand J Haematol; 1979 Nov; 23(5):437-41. PubMed ID: 542805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
    [No Abstract]   [Full Text] [Related]  

  • 16. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
    Walter E; Weber E; Loew D
    Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
    [No Abstract]   [Full Text] [Related]  

  • 17. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacology. Is there such a thing as a relevant drug interaction between oxazepam and phenprocoumon?].
    Schneider J; Kamm G
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1577-9. PubMed ID: 347785
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of interaction between ofloxacin and phenprocoumon.
    Verho M; Malerczyk V; Rosenkranz B; Grötsch H
    Curr Med Res Opin; 1987; 10(7):474-9. PubMed ID: 3476252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the interractions of cyclamate with phenprocomon (author's transl)].
    Kinawi A; Baumgartl I
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):345-8. PubMed ID: 894206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.